PRESS RELEASE published on 01/18/2024 at 13:00, 2 years ago Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
PRESS RELEASE published on 01/16/2024 at 13:00, 2 years ago Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
PRESS RELEASE published on 11/15/2023 at 13:00, 2 years 2 months ago Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
PRESS RELEASE published on 06/15/2023 at 13:00, 2 years 7 months ago OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
PRESS RELEASE published on 05/09/2023 at 13:00, 2 years 8 months ago Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
PRESS RELEASE published on 05/04/2023 at 13:00, 2 years 9 months ago Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
PRESS RELEASE published on 05/03/2023 at 15:05, 2 years 9 months ago Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
PRESS RELEASE published on 05/01/2023 at 13:00, 2 years 9 months ago Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
PRESS RELEASE published on 03/30/2023 at 13:00, 2 years 10 months ago Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
PRESS RELEASE published on 03/29/2023 at 17:45, 2 years 10 months ago Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Published on 02/05/2026 at 15:45, 12 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 47 minutes ago Electric Metals (USA) Limited Announces Change of Auditor
Published on 02/05/2026 at 14:50, 1 hour 7 minutes ago High Tide Resources Announces Non-Brokered Private Placements
Published on 02/05/2026 at 14:30, 1 hour 27 minutes ago Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:30, 1 hour 27 minutes ago Innodata to Report Fourth Quarter and Fiscal Year 2025 Results
Published on 02/05/2026 at 15:40, 17 minutes ago BIKE24 exceeds revenue and earnings forecast for fiscal year 2025 – strong growth in the fourth quarter
Published on 02/05/2026 at 15:34, 23 minutes ago EQS-Adhoc: Bike24 Holding AG: Preliminary sales and earnings exceed the previous forecast range for the 2025 financial year
Published on 02/05/2026 at 15:15, 42 minutes ago FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE
Published on 02/05/2026 at 11:30, 4 hours 27 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 4 hours 27 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 21 hours 53 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 21 hours 53 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 22 hours 12 minutes ago Information concerning the total number of voting rights and shares 2026 01 31